Aptamer Group (APTA) Competitors GBX 0.59 0.00 (0.00%) As of 11:04 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock APTA vs. ORPH, 4BB, REDX, ETX, and HVOShould you buy Aptamer Group stock or one of its competitors? MarketBeat compares Aptamer Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aptamer Group include Open Orphan (ORPH), 4basebio (4BB), Redx Pharma (REDX), e-therapeutics (ETX), and hVIVO (HVO). These companies are all part of the "biotechnology" industry. APTA vs. ORPHAPTA vs. 4BBAPTA vs. REDXAPTA vs. ETXAPTA vs. HVOHow does Aptamer Group compare to Open Orphan?Aptamer Group (LON:APTA) and Open Orphan (LON:ORPH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations. Is APTA or ORPH more profitable? Open Orphan has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. Open Orphan's return on equity of 0.00% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets Aptamer Group-178.52% -135.35% -44.96% Open Orphan N/A N/A N/A Does the media favor APTA or ORPH? In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled Open Orphan'saverage media sentiment score. Company Overall Sentiment Aptamer Group Neutral Open Orphan Neutral Which has preferable earnings & valuation, APTA or ORPH? Open Orphan has higher revenue and earnings than Aptamer Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptamer Group£1.38M14.72-£14.17M-£0.11N/AOpen Orphan£34.71M0.00N/AN/AN/A Do insiders and institutionals have more ownership in APTA or ORPH? 3.0% of Aptamer Group shares are owned by institutional investors. 8.8% of Aptamer Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryOpen Orphan beats Aptamer Group on 4 of the 7 factors compared between the two stocks.How does Aptamer Group compare to 4basebio?Aptamer Group (LON:APTA) and 4basebio (LON:4BB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations. Do analysts recommend APTA or 4BB? 4basebio has a consensus price target of GBX 1,600, indicating a potential upside of 256.59%. Given 4basebio's stronger consensus rating and higher probable upside, analysts clearly believe 4basebio is more favorable than Aptamer Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptamer Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.004basebio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to APTA or 4BB? In the previous week, 4basebio had 2 more articles in the media than Aptamer Group. MarketBeat recorded 2 mentions for 4basebio and 0 mentions for Aptamer Group. 4basebio's average media sentiment score of 0.49 beat Aptamer Group's score of 0.00 indicating that 4basebio is being referred to more favorably in the news media. Company Overall Sentiment Aptamer Group Neutral 4basebio Neutral Is APTA or 4BB more profitable? 4basebio has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. Aptamer Group's return on equity of -135.35% beat 4basebio's return on equity.Company Net Margins Return on Equity Return on Assets Aptamer Group-178.52% -135.35% -44.96% 4basebio N/A -231.29%-54.30% Do institutionals and insiders believe in APTA or 4BB? 3.0% of Aptamer Group shares are owned by institutional investors. Comparatively, 0.9% of 4basebio shares are owned by institutional investors. 8.8% of Aptamer Group shares are owned by company insiders. Comparatively, 12.1% of 4basebio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, APTA or 4BB? Aptamer Group has a beta of 0.903, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, 4basebio has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market. Which has higher earnings and valuation, APTA or 4BB? 4basebio has higher revenue and earnings than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than 4basebio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptamer Group£1.38M14.72-£14.17M-£0.11N/A4basebio£1.78M39.06-£9.84M-£99.00N/A Summary4basebio beats Aptamer Group on 12 of the 16 factors compared between the two stocks.How does Aptamer Group compare to Redx Pharma?Redx Pharma (LON:REDX) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership. Does the media favor REDX or APTA? In the previous week, Redx Pharma's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score. Company Overall Sentiment Redx Pharma Neutral Aptamer Group Neutral Is REDX or APTA more profitable? Redx Pharma has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. Aptamer Group's return on equity of -135.35% beat Redx Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Redx PharmaN/A -180.80% -43.95% Aptamer Group -178.52%-135.35%-44.96% Which has preferable valuation and earnings, REDX or APTA? Aptamer Group has lower revenue, but higher earnings than Redx Pharma. Aptamer Group is trading at a lower price-to-earnings ratio than Redx Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedx Pharma£4.20M0.00-£33.16M-£0.10N/AAptamer Group£1.38M14.72-£14.17M-£0.11N/A Which has more risk and volatility, REDX or APTA? Redx Pharma has a beta of -0.53, suggesting that its stock price is 153% less volatile than the broader market. Comparatively, Aptamer Group has a beta of 0.903, suggesting that its stock price is 10% less volatile than the broader market. Do insiders and institutionals hold more shares of REDX or APTA? 72.7% of Redx Pharma shares are owned by institutional investors. Comparatively, 3.0% of Aptamer Group shares are owned by institutional investors. 18.4% of Redx Pharma shares are owned by company insiders. Comparatively, 8.8% of Aptamer Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryRedx Pharma beats Aptamer Group on 6 of the 10 factors compared between the two stocks.How does Aptamer Group compare to e-therapeutics?e-therapeutics (LON:ETX) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation. Does the media prefer ETX or APTA? In the previous week, e-therapeutics' average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score. Company Overall Sentiment e-therapeutics Neutral Aptamer Group Neutral Is ETX or APTA more profitable? e-therapeutics has a net margin of 0.00% compared to Aptamer Group's net margin of -178.52%. e-therapeutics' return on equity of -38.75% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets e-therapeuticsN/A -38.75% -29.10% Aptamer Group -178.52%-135.35%-44.96% Which has stronger valuation & earnings, ETX or APTA? e-therapeutics has higher earnings, but lower revenue than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than e-therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioe-therapeutics£295K0.00-£10.06M-£0.02N/AAptamer Group£1.38M14.72-£14.17M-£0.11N/A Do insiders and institutionals have more ownership in ETX or APTA? 26.5% of e-therapeutics shares are held by institutional investors. Comparatively, 3.0% of Aptamer Group shares are held by institutional investors. 59.4% of e-therapeutics shares are held by insiders. Comparatively, 8.8% of Aptamer Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, ETX or APTA? e-therapeutics has a beta of 0.46, meaning that its stock price is 54% less volatile than the broader market. Comparatively, Aptamer Group has a beta of 0.903, meaning that its stock price is 10% less volatile than the broader market. Summarye-therapeutics beats Aptamer Group on 7 of the 10 factors compared between the two stocks.How does Aptamer Group compare to hVIVO?hVIVO (LON:HVO) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment. Which has more risk and volatility, HVO or APTA? hVIVO has a beta of 1.685, meaning that its stock price is 69% more volatile than the broader market. Comparatively, Aptamer Group has a beta of 0.903, meaning that its stock price is 10% less volatile than the broader market. Which has higher earnings & valuation, HVO or APTA? hVIVO has higher revenue and earnings than Aptamer Group. hVIVO is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£46.77M1.17£17.84M-£0.87N/AAptamer Group£1.38M14.72-£14.17M-£0.11N/A Do analysts prefer HVO or APTA? hVIVO currently has a consensus price target of GBX 15, suggesting a potential upside of 88.68%. Given hVIVO's stronger consensus rating and higher possible upside, research analysts plainly believe hVIVO is more favorable than Aptamer Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Aptamer Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to HVO or APTA? In the previous week, hVIVO had 1 more articles in the media than Aptamer Group. MarketBeat recorded 1 mentions for hVIVO and 0 mentions for Aptamer Group. hVIVO's average media sentiment score of 0.25 beat Aptamer Group's score of 0.00 indicating that hVIVO is being referred to more favorably in the media. Company Overall Sentiment hVIVO Neutral Aptamer Group Neutral Do institutionals & insiders have more ownership in HVO or APTA? 10.2% of hVIVO shares are held by institutional investors. Comparatively, 3.0% of Aptamer Group shares are held by institutional investors. 5.2% of hVIVO shares are held by company insiders. Comparatively, 8.8% of Aptamer Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is HVO or APTA more profitable? hVIVO has a net margin of -12.48% compared to Aptamer Group's net margin of -178.52%. hVIVO's return on equity of -14.65% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets hVIVO-12.48% -14.65% 11.97% Aptamer Group -178.52%-135.35%-44.96% SummaryhVIVO beats Aptamer Group on 12 of the 16 factors compared between the two stocks. Get Aptamer Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APTA vs. The Competition ExportMetricAptamer GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£19.87M£465.73M£6.25B£2.90BDividend YieldN/A3.87%2.80%6.17%P/E Ratio-5.343.7620.79365.16Price / Sales14.727,435.94531.2187,648.92Price / CashN/A13.1343.0927.89Price / Book2.7583.539.817.62Net Income-£14.17M-£96.07M£3.55B£5.89B7 Day Performance2.09%0.52%-2.07%0.11%1 Month Performance3.35%0.18%-3.90%0.27%1 Year Performance74.70%71.17%29.39%83.47% Aptamer Group Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAAptamer GroupN/AGBX 0.59flatN/A+67.7%£19.87M£1.38MN/A37ORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71MN/A1794BB4basebio1.8427 of 5 starsGBX 432.26flatGBX 1,600+270.2%-62.3%£66.94M£1.78MN/A101REDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20MN/A101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295KN/A35High Trading Volume Related Companies and Tools Related Companies Open Orphan Alternatives 4basebio Alternatives Redx Pharma Alternatives e-therapeutics Alternatives hVIVO Alternatives Roquefort Therapeutics Alternatives Hemogenyx Pharmaceuticals Alternatives Poolbeg Pharma Alternatives Collagen Solutions plc (COS.L) Alternatives C4X Discovery Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:APTA) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptamer Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptamer Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
